The Comparative Safety and Effectiveness of Bivalirudin Versus Heparin Monotherapy in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

BACKGROUND: Dialysis patients are at a higher risk of bleeding after PCI; however, due to their exclusion from randomized clinical trials, the optimal antithrombotic regimen for this population remains unknown. We sought to evaluate the comparative safety and effectiveness of bivalirudin monotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Catheter Cardiovasc Interv
Main Authors: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Khandelwal, Akshay, Cannon, Louis A., LaLonde, Thomas A., Gurm, Hitinder S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850212/
https://ncbi.nlm.nih.gov/pubmed/28303632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.27001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados